0000313616-22-000227.txt : 20221020 0000313616-22-000227.hdr.sgml : 20221020 20221019175855 ACCESSION NUMBER: 0000313616-22-000227 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20221020 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20221020 DATE AS OF CHANGE: 20221019 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DANAHER CORP /DE/ CENTRAL INDEX KEY: 0000313616 STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL INSTRUMENTS FOR MEASUREMENT, DISPLAY, AND CONTROL [3823] IRS NUMBER: 591995548 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-08089 FILM NUMBER: 221319382 BUSINESS ADDRESS: STREET 1: 2200 PENNSYLVANIA AVE. N.W. STREET 2: SUITE 800W CITY: WASHINGTON STATE: DC ZIP: 20037-1701 BUSINESS PHONE: 2028280850 MAIL ADDRESS: STREET 1: 2200 PENNSYLVANIA AVE. N.W. STREET 2: SUITE 800W CITY: WASHINGTON STATE: DC ZIP: 20037-1701 FORMER COMPANY: FORMER CONFORMED NAME: DMG INC DATE OF NAME CHANGE: 19850221 8-K 1 dhr-20221020.htm 8-K dhr-20221020
false000031361600003136162022-10-202022-10-200000313616us-gaap:CommonStockMember2022-10-202022-10-200000313616us-gaap:SeriesBPreferredStockMember2022-10-202022-10-200000313616dhr:A1.7SeniorNotesDue2024Member2022-10-202022-10-200000313616dhr:A0.2SeniorNotesDue2026Member2022-10-202022-10-200000313616dhr:A2.1SeniorNotesDue2026Member2022-10-202022-10-200000313616dhr:A1.2SeniorNotesDue2027Member2022-10-202022-10-200000313616dhr:A0.45SeniorNotesDue2028Member2022-10-202022-10-200000313616dhr:A2.5SeniorNotesDue2030Member2022-10-202022-10-200000313616dhr:A0.75SeniorNotesDue2031Member2022-10-202022-10-200000313616dhr:A1.35SeniorNotesDue2039Member2022-10-202022-10-200000313616dhr:A1.8SeniorNotesDue2049Member2022-10-202022-10-20

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
__________________
FORM 8-K
__________________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): October 20, 2022
__________________
dhr-20221020_g1.jpg
DANAHER CORPORATION
(Exact Name of Registrant as Specified in Its Charter)
__________________
Delaware001-0808959-1995548
(State or Other Jurisdiction of Incorporation)(Commission File Number)(IRS Employer Identification No.)
2200 Pennsylvania Avenue, N.W., 20037-1701
Suite 800W
Washington,DC
(Address of Principal Executive Offices) (Zip Code)
202-828-0850
(Registrant’s Telephone Number, Including Area Code)
Not applicable
(Former Name or Former Address, if Changed Since Last Report)
__________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common stock, $0.01 par valueDHRNew York Stock Exchange
5.00% Mandatory Convertible Preferred Stock, Series B, without par valueDHR.PRBNew York Stock Exchange
1.700% Senior Notes due 2024DHR 24New York Stock Exchange
0.200% Senior Notes due 2026DHR/26New York Stock Exchange
2.100% Senior Notes due 2026DHR 26New York Stock Exchange
1.200% Senior Notes due 2027DHR/27New York Stock Exchange
0.450% Senior Notes due 2028DHR/28New York Stock Exchange
2.500% Senior Notes due 2030DHR 30New York Stock Exchange
0.750% Senior Notes due 2031DHR/31New York Stock Exchange
1.350% Senior Notes due 2039DHR/39New York Stock Exchange
1.800% Senior Notes due 2049DHR/49New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ 





ITEM 2.02RESULTS OF OPERATIONS AND FINANCIAL CONDITION
On October 20, 2022, Danaher Corporation (“Danaher”) issued a press release announcing financial results for the quarter ended September 30, 2022. A copy of the release is furnished herewith as Exhibit 99.1 and incorporated by reference herein. This Current Report on Form 8-K and the press release attached hereto are being furnished by Danaher pursuant to Item 2.02 of Form 8-K.
This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

ITEM 9.01FINANCIAL STATEMENTS AND EXHIBITS
(c)Exhibits:
Exhibit No.  Description
99.1   
104 The cover page from this Current Report on Form 8-K, formatted as Inline XBRL.



SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
DANAHER CORPORATION
Date:October 19, 2022By:/s/ Matthew R. McGrew
Matthew R. McGrew
Executive Vice President and Chief Financial Officer


 EX-99.1 2 dhr-20221020xex991.htm EX-99.1 Document

Exhibit 99.1
dhrlogofor8ksa62.jpg

DANAHER REPORTS THIRD QUARTER 2022 RESULTS
WASHINGTON, D.C., October 20, 2022 -- Danaher Corporation (NYSE: DHR) (the “Company”) today announced results for the third quarter 2022. All results in this release reflect only continuing operations unless otherwise noted.
For the quarter ended September 30, 2022, net earnings were $1.6 billion, or $2.10 per diluted common share which represents a 36.0% year-over-year increase from the comparable 2021 period. Non-GAAP adjusted diluted net earnings per common share for the quarter ended September 30, 2022 were $2.56 which represents a 7.0% increase over the comparable 2021 period.
Revenues increased 6.0% year-over-year in the third quarter of 2022 to $7.7 billion. Non-GAAP core revenue growth was 10.0%, including 8.5% non-GAAP base business core revenue growth.
Operating cash flow for the third quarter of 2022 was $2.0 billion and non-GAAP free cash flow was $1.7 billion.
For the fourth quarter 2022, the Company anticipates that non-GAAP base business core revenue growth will be in the high-single digit percent range. For the full year 2022, the Company is increasing its expectation for non-GAAP core revenue growth to the high-single digit percent range, which includes non-GAAP base business core revenue growth in the high-single digit percent range.
Rainer M. Blair, President and Chief Executive Officer, stated, “We are pleased with our third quarter performance. The team maintained strong momentum in a challenging operating environment to deliver double-digit core revenue growth and solid margin expansion, earnings growth and cash flow generation. Our growth was broad-based across all three segments, a testament to the durability and attractive end-market positioning of the franchises that comprise Danaher.”
Blair continued, “As we look ahead, we believe the strength of our portfolio combined with our talented team and the power of the Danaher Business System provides a strong foundation to continue delivering meaningful shareholder value through 2022 and beyond.”
Danaher will discuss its results during its quarterly investor conference call today starting at 8:00 a.m. ET. The call and an accompanying slide presentation will be webcast on the “Investors” section of Danaher’s website, www.danaher.com, under the subheading “Events & Presentations” and additional materials will be posted to the same section of Danaher’s website. A replay of the webcast will be available in the same section of Danaher’s website shortly after the conclusion of the presentation and will remain available until the next quarterly earnings call.
The conference call can be accessed by dialing 800-895-3361 within the U.S. or by dialing +1-785-424-1062 outside the U.S. a few minutes before the 8:00 a.m. ET start and telling the operator that you are dialing in for Danaher’s earnings conference call (Conference ID: DHRQ322). A replay of the conference call will be available shortly after the conclusion of the call and until November 3, 2022. You can access the replay dial-in information on the “Investors” section of Danaher’s website under the subheading “Events & Presentations.” In addition, presentation materials relating to Danaher’s results have been posted to the “Investors” section of Danaher’s website under the subheading “Quarterly Earnings.”

ABOUT DANAHER
Danaher is a global science and technology innovator committed to helping its customers solve complex challenges and improving quality of life around the world. Its family of world class brands has leadership positions in the demanding and attractive health care, environmental and applied end-markets. With more than 20 operating companies, Danaher's globally diverse team of approximately 80,000 associates is united by a common culture and operating system, the Danaher Business System, and its Shared Purpose, Helping Realize Life's Potential. For more information, please visit www.danaher.com.

NON-GAAP MEASURES
In addition to the financial measures prepared in accordance with generally accepted accounting principles (GAAP), this earnings release also contains non-GAAP financial measures. Calculations of these measures, the reasons why we believe these measures provide useful information to investors, a reconciliation of these measures to the most directly comparable GAAP measures, as applicable, and other information relating to these non-GAAP measures are included in the supplemental reconciliation schedule attached.

1

FORWARD-LOOKING STATEMENTS
Statements in this release that are not strictly historical, including the statements regarding the Company's expected financial performance for the fourth quarter and full year 2022, Danaher’s prospects, future shareholder value generation and any other statements regarding events or developments that we believe or anticipate will or may occur in the future are "forward-looking" statements within the meaning of the federal securities laws. There are a number of important factors that could cause actual results, developments and business decisions to differ materially from those suggested or indicated by such forward-looking statements and you should not place undue reliance on any such forward-looking statements. These factors include, among other things, the highly uncertain and unpredictable severity, magnitude and duration of the COVID-19 pandemic (and the related governmental, business and community responses thereto) on our business, results of operations and financial condition, the impact of our debt obligations on our operations and liquidity, deterioration of or instability in the economy, the markets we serve and the financial markets (including as a result of the COVID-19 pandemic), uncertainties relating to U.S. laws or policies, including potential changes in U.S. trade policies and tariffs and the reaction of other countries thereto, contractions or growth rates and cyclicality of markets we serve, competition, our ability to develop and successfully market new products and technologies and expand into new markets, the potential for improper conduct by our employees, agents or business partners, our compliance with applicable laws and regulations (including rules relating to off-label marketing and other regulations relating to medical devices and the health care industry), the results of our clinical trials and perceptions thereof, our ability to effectively address cost reductions and other changes in the health care industry, our ability to successfully identify and consummate appropriate acquisitions and strategic investments and successfully complete divestitures and other dispositions, our ability to integrate the businesses we acquire and achieve the anticipated growth, synergies and other benefits of such acquisitions, contingent liabilities and other risks relating to acquisitions, investments, strategic relationships and divestitures (including tax-related and other contingent liabilities relating to past and future IPOs, split-offs or spin-offs), security breaches or other disruptions of our information technology systems or violations of data privacy laws, the impact of our restructuring activities on our ability to grow, risks relating to potential impairment of goodwill and other intangible assets, currency exchange rates, tax audits and changes in our tax rate and income tax liabilities, changes in tax laws applicable to multinational companies, litigation and other contingent liabilities including intellectual property and environmental, health and safety matters, the rights of the United States government to use, disclose and license certain intellectual property we license if we fail to commercialize it, risks relating to product, service or software defects, product liability and recalls, risks relating to product manufacturing, our relationships with and the performance of our channel partners, uncertainties relating to collaboration arrangements with third-parties, commodity costs and surcharges, our ability to adjust purchases and manufacturing capacity to reflect market conditions, reliance on sole sources of supply, the impact of deregulation on demand for our products and services, the impact of climate change, or legal or regulatory measures to address climate change, labor matters and our ability to recruit, retain and motivate talented employees, international economic, political, legal, compliance, social and business factors (including the impact of the military conflict between Russia and Ukraine and the United Kingdom's separation from the European Union), disruptions relating to man-made and natural disasters (including pandemics such as COVID-19), pension plan costs, inflation and supply chain disruption. Additional information regarding the factors that may cause actual results to differ materially from these forward-looking statements is available in our SEC filings, including our 2021 Annual Report on Form 10-K and Quarterly Report on Form 10-Q for the third quarter of 2022. These forward-looking statements speak only as of the date of this release and except to the extent required by applicable law, the Company does not assume any obligation to update or revise any forward-looking statement, whether as a result of new information, future events and developments or otherwise.

CONTACT
John T. Bedford
Vice President, Investor Relations
Danaher Corporation
2200 Pennsylvania Avenue, N.W., Suite 800W
Washington, D.C. 20037
Telephone: (202) 828-0850
Fax: (202) 828-0860

2

DANAHER CORPORATION AND SUBSIDIARIES
CONSOLIDATED CONDENSED STATEMENTS OF EARNINGS
($ and shares in millions, except per share amounts)
(unaudited)
 Three-Month Period EndedNine-Month Period Ended
 September 30, 2022October 1, 2021September 30, 2022October 1, 2021
Sales$7,663 $7,229 $23,102 $21,305 
Cost of sales(3,079)(2,870)(9,092)(8,296)
Gross profit4,584 4,359 14,010 13,009 
Operating costs:
Selling, general and administrative expenses(2,149)(2,062)(6,326)(5,904)
Research and development expenses(420)(441)(1,292)(1,247)
Other operating expenses— (547)— (547)
Operating profit2,015 1,309 6,392 5,311 
Nonoperating income (expense):
Other income (expense), net(51)137 (158)374 
Interest expense(42)(62)(147)(182)
Interest income9 3 12 10 
Earnings from continuing operations before income taxes1,931 1,387 6,099 5,513 
Income taxes(359)(229)(1,122)(954)
Net earnings from continuing operations1,572 1,158 4,977 4,559 
Earnings from discontinued operations, net of income taxes— — — 86 
Net earnings 1,572 1,158 4,977 4,645 
Mandatory convertible preferred stock dividends(21)(41)(84)(123)
Net earnings attributable to common stockholders$1,551 $1,117 $4,893 $4,522 
Net earnings per common share from continuing operations:
Basic$2.13 $1.56 $6.76 $6.21 
Diluted$2.10 $1.54 $6.67 
(a)
$6.10 
(a)
Net earnings per common share from discontinued operations:
Basic$— $— $— $0.12 
Diluted$— $— $— $0.12 
Net earnings per common share:
Basic$2.13 $1.56 $6.76 $6.33 
Diluted$2.10 $1.54 $6.67 
(a)
$6.22 
(a)
Average common stock and common equivalent shares outstanding:
Basic728.5 715.1 723.8 714.3 
Diluted737.4 727.0 737.0 736.4 
(a) Net earnings per common share amounts for the relevant three-month periods do not add to the nine-month period amount due to rounding.

This information is presented for reference only. A complete copy of Danaher’s Form 10-Q financial statements is available on the Company’s website (www.danaher.com).
3

DANAHER CORPORATION
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES
Adjusted Diluted Net Earnings Per Common Share from Continuing Operations 1
Three-Month Period EndedNine-Month Period Ended
September 30, 2022October 1, 2021September 30, 2022October 1, 2021
Diluted Net Earnings Per Common Share From Continuing Operations (GAAP)$2.10 $1.54 $6.67 $6.10 
Amortization of acquisition-related intangible assets A
0.48 0.49 1.50 1.42 
Fair value net (gains) losses on investments B
0.09 (0.17)0.25 (0.44)
Impairments and other charges C
— — 0.07 0.01 
Loss on partial settlement of a defined benefit plan D
— — 0.01 — 
Acquisition-related items E
— 0.06 — 0.12 
Gain on disposition of certain product lines F
— — — (0.02)
Contract settlement expense G
— 0.73 — 0.73 
Tax effect of the above adjustments H
(0.11)(0.24)(0.36)(0.39)
Discrete tax adjustments I
— (0.03)(0.07)(0.19)
MCPS "as if converted" J
— 0.01 0.01 0.02 
Adjusted Diluted Net Earnings Per Common Share From Continuing Operations (Non-GAAP)$2.56 $2.39 $8.08 $7.36 
1    Each of the per share adjustment amounts above have been calculated assuming the Mandatory Convertible Preferred Stock (“MCPS”) had been converted into shares of common stock.

Adjusted Average Common Stock and Common Equivalent Diluted Shares Outstanding
(shares in millions)
 Three-Month Period EndedNine-Month Period Ended
 September 30, 2022October 1, 2021September 30, 2022October 1, 2021
Average common stock and common equivalent shares outstanding - diluted (GAAP) 2
737.4 727.0 737.0 736.4 
Converted shares 3
8.6 19.6 8.6 8.6 
Adjusted average common stock and common equivalent shares outstanding - diluted (non-GAAP)746.0 746.6 745.6 745.0 
2    The impact of the MCPS Series A calculated under the if-converted method was dilutive for the nine-month periods ended September 30, 2022 and October 1, 2021, and as such 4.0 million shares and 11.0 million shares, respectively, underlying the MCPS Series A were included in the calculation of diluted EPS. The related MCPS Series A dividends of $20 million and $59 million for the nine-month periods ended September 30, 2022 and October 1, 2021, respectively, were excluded from the calculation of net earnings for diluted EPS. The impact of the MCPS Series A calculated under the if-converted method was anti-dilutive for the three-month period ended October 1, 2021, and as such 11.0 million shares underlying the MCPS Series A were excluded from the calculation of diluted EPS for the three-month period and the related MCPS Series A dividends of $19 million were included in the calculation of net earnings for diluted EPS for the period. On April 15, 2022, all outstanding shares of the MCPS Series A converted into 11.0 million shares of the Company’s common stock. There were no MCPS Series A dividends declared in the second quarter of 2022 prior to their conversion and the MCPS Series A were dilutive for all periods prior to the conversion.
The impact of the MCPS Series B calculated under the if-converted method was anti-dilutive for both the three and nine-month periods ended September 30, 2022 and October 1, 2021, and as such 8.6 million shares, for both the three and nine-month periods underlying the MCPS Series B were excluded from the calculation of diluted EPS and the related MCPS Series B dividends of $21 million and $22 million for the three-month periods, respectively, and $64 million for both nine-month periods were included in the calculation of net earnings for diluted EPS.
3    The number of converted shares assumes the conversion of all MCPS and issuance of the underlying shares applying the “if-converted” method of accounting and using an average 20 trading-day trailing volume weighted average price (“VWAP”) of $274.64 and $320.10 as of September 30, 2022 and October 1, 2021, respectively.

See the accompanying Notes to Reconciliation of GAAP to Non-GAAP Financial Measures.
4

DANAHER CORPORATION
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES
(continued)
Core Sales Growth and Base Business Core Sales Growth
% Change Three-Month Period Ended September 30, 2022 vs. Comparable 2021 Period% Change Nine-Month Period Ended September 30, 2022 vs. Comparable 2021 Period
Total sales growth (GAAP)6.0 %8.5 %
Impact of:
Acquisitions/divestitures(1.5)%(2.0)%
Currency exchange rates 5.5 %4.0 %
Core sales growth (non-GAAP)10.0 %10.5 %
Impact of COVID-19 related testing(1.5)%(2.5)%
Base business core sales growth (non-GAAP)8.5 %8.0 %
Note: While we expect overall demand for the Company’s COVID-19 related products to moderate as and to the extent the pandemic subsides, as the pandemic evolves toward endemic status we believe a level of demand for the Company’s products that support COVID-19 related vaccines and therapeutics (including initiatives that seek to prevent or mitigate similar, future pandemics) and COVID-19 testing will continue. However, on a relative basis, we expect the level of ongoing demand for products supporting COVID-19 testing will be subject to more fluctuations in demand than the level of demand for products supporting COVID-19 related vaccines and therapeutics. Therefore, beginning with the first quarter of 2022, in addition to disclosing core revenue growth, we disclose “base business core sales growth” on a basis that excludes revenues related to COVID-19 testing and includes revenues from products that support COVID-19 related vaccines and therapeutics. We believe this additional measure provides useful information to investors by facilitating period-to-period comparisons of our financial performance and identifying underlying growth trends in the Company’s business that otherwise may be obscured by fluctuations in demand for COVID-19 testing as a result of the pandemic.
Forecasted Core Sales Growth and Base Business Core Sales Growth 4
% Change Three-Month Period Ending December 31, 2022 vs. Comparable 2021 Period% Change Year Ending December 31, 2022 vs. Comparable 2021 Period
Core sales growth (non-GAAP)Flat to
(low-single digit)		+High-single digit
Impact of COVID-19 related testing+High-single to
low-double digit		— %
Base business core sales growth (non-GAAP)+High-single digit+High-single digit
4    We do not reconcile these measures to the comparable GAAP measure because of the inherent difficulty in predicting and estimating the future impact and timing of currency translation, acquisitions and divested product lines, which would be reflected in any forecasted GAAP revenue.


See the accompanying Notes to Reconciliation of GAAP to Non-GAAP Financial Measures.
5

DANAHER CORPORATION
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES
(continued)
Free Cash Flow from Continuing Operations and Free Cash Flow from Continuing Operations to Net Earnings from Continuing Operations Conversion Ratio
($ in millions)
Three-Month Period EndedYear-over-Year Change
September 30, 2022October 1, 2021
Total Cash Flows from Continuing Operations:
Net cash provided by operating activities from continuing operations (GAAP)$2,010 $2,034 
Total cash used in investing activities from continuing operations (GAAP)$(515)$(10,048)
Total cash (used in) provided by financing activities from continuing operations (GAAP)$(230)$3,305 
Free Cash Flow from Continuing Operations:
Net cash provided by operating activities from continuing operations (GAAP)$2,010 $2,034 ~ (1.0)%
Less: payments for additions to property, plant & equipment (capital expenditures) from continuing operations (GAAP)(277)(318)
Plus: proceeds from sales of property, plant & equipment (capital disposals) from continuing operations (GAAP)— — 
Free cash flow from continuing operations (non-GAAP)$1,733 $1,716 ~ 1.0 %
Free Cash Flow from Continuing Operations to Net Earnings from Continuing Operations Conversion Ratio:
Free cash flow from continuing operations from above (non-GAAP)$1,733 $1,716 
Net earnings from continuing operations (GAAP)1,572 1,158 
Free cash flow from continuing operations to net earnings from continuing operations conversion ratio (non-GAAP) 1.101.48
We define free cash flow from continuing operations as operating cash flows from continuing operations, less payments for additions to property, plant and equipment from continuing operations (“capital expenditures”) plus the proceeds from sales of plant, property and equipment from continuing operations (“capital disposals”). All amounts presented above reflect only continuing operations.    


See the accompanying Notes to Reconciliation of GAAP to Non-GAAP Financial Measures.
6

DANAHER CORPORATION
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES
(continued)
Notes to Reconciliation of GAAP to Non-GAAP Financial Measures
A    Amortization of acquisition-related intangible assets in the following historical periods ($ in millions) (only the pretax amounts set forth below are reflected in the amortization line item above):
Three-Month Period EndedNine-Month Period Ended
September 30, 2022October 1, 2021September 30, 2022October 1, 2021
Pretax$361 $365 $1,120 $1,056 
After-tax293 293 904 842 
B    Net (gains) losses on the Company's equity and limited partnership investments recorded in the following historical periods ($ in millions) (only the pretax amounts set forth below are reflected in the fair value net (gains) losses on investments line above):
Three-Month Period EndedNine-Month Period Ended
September 30, 2022October 1, 2021September 30, 2022October 1, 2021
Pretax$64 $(128)$186 $(330)
After-tax48 (97)141 (258)
C        Impairment charges related to technology and customer relationships in the Environmental & Applied Solutions segment recorded in the nine-month period ended September 30, 2022 ($9 million pretax as reported in this line item, $7 million after-tax). Additionally, in the nine-month period ended September 30, 2022, charges incurred primarily related to impairments of accounts receivable and inventory as well as accruals for contractual obligations in Russia ($43 million pretax as reported in this line item, $40 million after-tax). Impairment charges related to a trade name in the Diagnostics segment recorded in the nine-month period ended October 1, 2021 ($10 million pretax as reported in this line item, $8 million after-tax).
D    Loss on a partial settlement of a defined benefit plan as a result of the transfer of a portion of the Company’s non-U.S. pension liabilities related to one defined benefit plan to a third-party in the nine-month period ended September 30, 2022 ($10 million pretax as reported in this line item, $9 million after-tax).
E    Costs incurred for fair value adjustments to inventory and transaction costs deemed significant related to the acquisition of Aldevron in the three-month period ended October 1, 2021 ($45 million pretax as reported in this line item, $36 million after-tax). Costs incurred for fair value adjustments to inventory and deferred revenue and transaction costs deemed significant related to the acquisitions of Cytiva and Aldevron in the nine-month period ended October 1, 2021 ($91 million pretax as reported in this line item, $72 million after-tax). The Company deems acquisition-related transaction costs incurred in a given period to be significant (generally relating to the Company’s larger acquisitions) if it determines that such costs exceed the range of acquisition-related transaction costs typical for Danaher in a given period.
F    Gain on disposition of certain product lines in the nine-month period ended October 1, 2021 ($13 million pretax as reported in this line item, $10 million after-tax).
G    Expense related to the modification and partial termination of a prior commercial arrangement and resolution of the associated litigation in both the three and nine-month periods ended October 1, 2021 ($547 million pretax as reported in this line item, $415 million after-tax).
H    This line item reflects the aggregate tax effect of all nontax adjustments reflected in the preceding line items of the table. In addition, the footnotes above indicate the after-tax amount of each individual adjustment item. Danaher estimates the tax effect of each adjustment item by applying Danaher’s overall estimated effective tax rate to the pretax amount, unless the nature of the item and/or the tax jurisdiction in which the item has been recorded requires application of a specific tax rate or tax treatment, in which case the tax effect of such item is estimated by applying such specific tax rate or tax treatment. The MCPS dividends are not tax deductible and therefore the tax effect of the adjustments does not include any tax impact of the MCPS dividends.
I    Discrete tax adjustments and other tax-related adjustments for the three-month period ended September 30, 2022, include the impact of net discrete tax benefits of $3 million related primarily to excess tax benefits from stock-based compensation partially offset by changes in estimates associated with prior period uncertain tax positions. Discrete tax adjustments and other tax-related adjustments for the nine-month period ended September 30, 2022, include the impact of net discrete tax benefits of $52 million related primarily to excess tax benefits from stock-based compensation and changes in estimates associated with prior period uncertain tax positions. Discrete tax adjustments and other tax-related adjustments for the three-month period ended October 1, 2021, include the impact of net discrete tax benefits of $23 million related primarily to
7

DANAHER CORPORATION
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES
(continued)
excess tax benefits from stock-based compensation, audit settlements and a higher tax benefit associated with the pretax charge in the quarter related to the modification and partial termination of a commercial arrangement and the resolution of the associated litigation. Discrete tax adjustments and other tax-related adjustments for the nine-month period ended October 1, 2021, include the impact of net discrete tax benefits of $143 million related primarily to the release of reserves for uncertain tax positions due to the expiration of statutes of limitation, audit settlements, excess tax benefits from stock-based compensation and a higher tax benefit associated with the pretax charge in the period related to the modification and partial termination of a commercial arrangement and the resolution of the associated litigation, net of changes in estimates associated with prior period uncertain tax positions.
J    In March 2019, the Company issued $1.65 billion in aggregate liquidation preference of 4.75% MCPS Series A. In May 2020, the Company issued $1.72 billion in aggregate liquidation preference of 5.0% MCPS Series B. Dividends on the MCPS Series A were, and on the Series B are, payable on a cumulative basis at an annual rate of 4.75% and 5.0%, respectively, on the liquidation preference of $1,000 per share. Each share of MCPS Series A converted on April 15, 2022 into 6.6632 shares of Danaher’s common stock. Unless earlier converted, each share of MCPS Series B will automatically convert on April 15, 2023 into between 5.0143 and 6.1425 shares of Danaher’s common stock, subject to further anti-dilution adjustments. The number of shares of Danaher’s common stock issuable on conversion of the MCPS is determined based on the VWAP per share of the Company's common stock over the 20 consecutive trading day period beginning on, and including, the 21st scheduled trading day immediately before April 15, 2023 for the Series B. For the calculation of net earnings per common share from continuing operations, the impact of the dilutive MCPS is calculated under the if-converted method and the related MCPS dividends are excluded. For the purposes of calculating adjusted earnings per common share from continuing operations, the Company has excluded the paid and anticipated MCPS cash dividends and assumed the “if-converted” method of share dilution (the incremental shares of common stock deemed outstanding applying the “if-converted” method of calculating share dilution only with respect to any MCPS the conversion of which would be dilutive in the particular period are referred to as the “Converted Shares”) for any MCPS that were anti-dilutive for the given period. For additional information about the impact of the MCPS on the calculation of diluted EPS, see note 2 in the Adjusted Average Common Stock and Common Equivalent Diluted Shares Outstanding table above.

8

Statement Regarding Non-GAAP Measures
Each of the non-GAAP measures set forth above should be considered in addition to, and not as a replacement for or superior to, the comparable GAAP measure, and may not be comparable to similarly titled measures reported by other companies.  Management believes that these measures provide useful information to investors by offering additional ways of viewing Danaher Corporation’s (“Danaher” or the “Company”) results that, when reconciled to the corresponding GAAP measure, help our investors to:
•with respect to Adjusted Diluted Net Earnings Per Common Share from Continuing Operations, understand the long-term profitability trends of our business and compare our profitability to prior and future periods and to our peers;
•with respect to core sales and related sales measures, identify underlying growth trends in our business and compare our sales performance with prior and future periods and to our peers; and
•with respect to free cash flow from continuing operations and related cash flow measures (the “FCF Measure”), understand Danaher’s ability to generate cash without external financings, strengthen its balance sheet, invest in its business and grow its business through acquisitions and other strategic opportunities (although a limitation of free cash flow is that it does not take into account the Company’s debt service requirements and other non-discretionary expenditures, and as a result the entire free cash flow amount is not necessarily available for discretionary expenditures).
While we expect overall demand for the Company’s COVID-19 related products to moderate as and to the extent the pandemic subsides, as the pandemic evolves toward endemic status we believe a level of demand for the Company’s products that support COVID-19 related vaccines and therapeutics (including initiatives that seek to prevent or mitigate similar, future pandemics) and COVID-19 testing will continue. However, on a relative basis, we expect the level of ongoing demand for products supporting COVID-19 testing will be subject to more fluctuations in demand than the level of demand for products supporting COVID-19 related vaccines and therapeutics. Therefore, beginning with the first quarter of 2022, in addition to disclosing core revenue growth, we disclose “base business core sales growth” on a basis that excludes revenues related to COVID-19 testing and includes revenues from products that support COVID-19 related vaccines and therapeutics. We believe this additional measure provides useful information to investors by facilitating period-to-period comparisons of our financial performance and identifying underlying growth trends in the Company’s business that otherwise may be obscured by fluctuations in demand for COVID-19 testing as a result of the pandemic.
Management uses these non-GAAP measures to measure the Company’s operating and financial performance, and uses core sales and non-GAAP measures similar to Adjusted Diluted Net Earnings Per Common Share from Continuing Operations and the FCF Measure in the Company’s executive compensation program.
The items excluded from the non-GAAP measures set forth above have been excluded for the following reasons:
•With respect to Adjusted Diluted Net Earnings Per Common Share from Continuing Operations:
◦Amortization of Intangible Assets. We exclude the amortization of acquisition-related intangible assets because the amount and timing of such charges are significantly impacted by the timing, size, number and nature of the acquisitions we consummate. While we have a history of significant acquisition activity we do not acquire businesses on a predictable cycle, and the amount of an acquisition’s purchase price allocated to intangible assets and related amortization term are unique to each acquisition and can vary significantly from acquisition to acquisition. Exclusion of this amortization expense facilitates more consistent comparisons of operating results over time between our newly acquired and long-held businesses, and with both acquisitive and non-acquisitive peer companies. We believe however that it is important for investors to understand that such intangible assets contribute to sales generation and that intangible asset amortization related to past acquisitions will recur in future periods until such intangible assets have been fully amortized.
◦Restructuring Charges. We exclude costs incurred pursuant to discrete restructuring plans that are fundamentally different (in terms of the size, strategic nature and planning requirements, as well as the inconsistent frequency, of such plans) from the ongoing productivity improvements that result from application of the Danaher Business System. Because these restructuring plans are incremental to the core activities that arise in the ordinary course of our business and we believe are not indicative of Danaher’s ongoing operating costs in a given period, we exclude these costs to facilitate a more consistent comparison of operating results over time.
9

◦Other Adjustments. With respect to the other items excluded from Adjusted Diluted Net Earnings Per Common Share from Continuing Operations, we exclude these items because they are of a nature and/or size that occur with inconsistent frequency, occur for reasons that may be unrelated to Danaher's commercial performance during the period and/or we believe that such items may obscure underlying business trends and make comparisons of long-term performance difficult. For example, we excluded the first quarter 2022 charge for asset impairments, accruals for contractual obligations and similar items related to our Russia operations because, even though it is possible we could incur additional charges in the future, we do not believe these charges are indicative of Danaher’s ongoing operating costs.
•With respect to adjusted average common stock and common equivalent shares outstanding, Danaher’s Mandatory Convertible Preferred Stock (“MCPS”) Series A converted into Danaher common stock on April 15, 2022 and MCPS Series B will mandatorily convert into Danaher common stock on the mandatory conversion date, which is expected to be April 15, 2023 (unless converted or redeemed earlier in accordance with the terms of the applicable certificate of designations). With respect to the calculation of Adjusted Diluted Net Earnings Per Common Share from Continuing Operations, we apply the “if converted” method of share dilution to the MCPS Series A and B in all applicable periods irrespective of whether such preferred shares would be dilutive or anti-dilutive in the period. We believe this presentation provides useful information to investors by helping them understand what the net impact will be on Danaher’s earnings per share-related measures once the MCPS convert into Danaher common stock.
•With respect to core sales related measures, (1) we exclude the impact of currency translation because it is not under management’s control, is subject to volatility and can obscure underlying business trends, and (2) we exclude the effect of acquisitions and divested product lines because the timing, size, number and nature of such transactions can vary significantly from period-to-period and between us and our peers, which we believe may obscure underlying business trends and make comparisons of long-term performance difficult.
•With respect to the FCF Measure, we exclude payments for additions to property, plant and equipment (net of the proceeds from capital disposals) to demonstrate the amount of operating cash flow for the period that remains after accounting for the Company’s capital expenditure requirements.
With respect to forecasted core sales related measures, we do not reconcile these measures to the comparable GAAP measure because of the inherent difficulty in predicting and estimating the future impact and timing of currency translation, acquisitions and divested product lines, which would be reflected in any forecasted GAAP revenue.

10
 EX-101.SCH 3 dhr-20221020.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001001 - Document - Document And Entity Information Document And Entity Information link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 4 dhr-20221020_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 5 dhr-20221020_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT 1.200% Senior Notes due 2027 1.2% Senior Notes Due 2027 [Member] 1.2% Senior Notes Due 2027 [Member] Entity central index key Entity Central Index Key Entity address, address line two Entity Address, Address Line Two Entity address, address line one Entity Address, Address Line One 2.100% Senior Notes due 2026 2.1% Senior Notes Due 2026 [Member] 2.1% Senior Notes Due 2026 [Member] Trading symbol Trading Symbol Entity file number Entity File Number Soliciting material Soliciting Material 0.200% Senior Notes due 2026 0.2% Senior Notes Due 2026 [Member] 0.2% Senior Notes Due 2026 [Member] Entity incorporation, state Entity Incorporation, State or Country Code 5.00% Mandatory Convertible Preferred Stock, Series B, without par value Series B Preferred Stock [Member] 1.700% Senior Notes due 2024 1.7% Senior Notes Due 2024 [Member] 1.7% Senior Notes Due 202 [Member] Class of Stock [Domain] Class of Stock [Domain] Entity address, postal zip code Entity Address, Postal Zip Code Entity Listings [Line Items] Entity Listings [Line Items] City area code City Area Code 0.450% Senior Notes due 2028 0.45% Senior Notes Due 2028 [Member] 0.45% Senior Notes Due 2028 [Member] Title of 12(b) security Title of 12(b) Security Entity Listings [Table] Entity Listings [Table] Amendment flag Amendment Flag Security exchange name Security Exchange Name Entity registrant name Entity Registrant Name Document period end date Document Period End Date 2.500% Senior Notes due 2030 2.5% Senior Notes Due 2030 [Member] 2.5% Senior Notes Due 2030 [Member] Entity tax identification number Entity Tax Identification Number Common stock, $0.01 par value Common Stock [Member] Pre-commencement issuer tender offer Pre-commencement Issuer Tender Offer Class of Stock [Axis] Class of Stock [Axis] Entity address, city Entity Address, City or Town Local phone number Local Phone Number Written communications Written Communications Cover [Abstract] Cover [Abstract] 1.350% Senior Notes due 2039 1.35% Senior Notes Due 2039 [Member] 1.35% Senior Notes Due 2039 [Member] Document type Document Type 1.800% Senior Notes due 2049 1.8% Senior Notes Due 2049 [Member] 1.8% Senior Notes Due 2049 [Member] Entity emerging growth company Entity Emerging Growth Company Entity address, state Entity Address, State or Province 0.750% Senior Notes due 2031 0.75% Senior Notes Due 2031 [Member] 0.75% Senior Notes Due 2031 [Member] Pre-commencement tender offer Pre-commencement Tender Offer EX-101.PRE 6 dhr-20221020_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 7 dhr-20221020_g1.jpg begin 644 dhr-20221020_g1.jpg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end GRAPHIC 8 dhrlogofor8ksa62.jpg begin 644 dhrlogofor8ksa62.jpg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end XML 9 R1.htm IDEA: XBRL DOCUMENT v3.22.2.2
Document And Entity Information Document And Entity Information
Oct. 20, 2022
Cover [Abstract]  
Document type 8-K
Document period end date Oct. 20, 2022
Entity registrant name DANAHER CORPORATION
Entity incorporation, state DE
Entity file number 001-08089
Entity tax identification number 59-1995548
Entity address, address line one 2200 Pennsylvania Avenue, N.W.,
Entity address, address line two Suite 800W
Entity address, city Washington,
Entity address, state DC
Entity address, postal zip code 20037-1701
City area code 202
Local phone number 828-0850
Written communications false
Soliciting material false
Pre-commencement tender offer false
Pre-commencement issuer tender offer false
Entity emerging growth company false
Amendment flag false
Entity central index key 0000313616
Common stock, $0.01 par value  
Entity Listings [Line Items]  
Title of 12(b) security Common stock, $0.01 par value
Trading symbol DHR
Security exchange name NYSE
5.00% Mandatory Convertible Preferred Stock, Series B, without par value  
Entity Listings [Line Items]  
Title of 12(b) security 5.00% Mandatory Convertible Preferred Stock, Series B, without par value
Trading symbol DHR.PRB
Security exchange name NYSE
1.700% Senior Notes due 2024  
Entity Listings [Line Items]  
Title of 12(b) security 1.700% Senior Notes due 2024
Trading symbol DHR 24
Security exchange name NYSE
0.200% Senior Notes due 2026  
Entity Listings [Line Items]  
Title of 12(b) security 0.200% Senior Notes due 2026
Trading symbol DHR/26
Security exchange name NYSE
2.100% Senior Notes due 2026  
Entity Listings [Line Items]  
Title of 12(b) security 2.100% Senior Notes due 2026
Trading symbol DHR 26
Security exchange name NYSE
1.200% Senior Notes due 2027  
Entity Listings [Line Items]  
Title of 12(b) security 1.200% Senior Notes due 2027
Trading symbol DHR/27
Security exchange name NYSE
0.450% Senior Notes due 2028  
Entity Listings [Line Items]  
Title of 12(b) security 0.450% Senior Notes due 2028
Trading symbol DHR/28
Security exchange name NYSE
2.500% Senior Notes due 2030  
Entity Listings [Line Items]  
Title of 12(b) security 2.500% Senior Notes due 2030
Trading symbol DHR 30
Security exchange name NYSE
0.750% Senior Notes due 2031  
Entity Listings [Line Items]  
Title of 12(b) security 0.750% Senior Notes due 2031
Trading symbol DHR/31
Security exchange name NYSE
1.350% Senior Notes due 2039  
Entity Listings [Line Items]  
Title of 12(b) security 1.350% Senior Notes due 2039
Trading symbol DHR/39
Security exchange name NYSE
1.800% Senior Notes due 2049  
Entity Listings [Line Items]  
Title of 12(b) security 1.800% Senior Notes due 2049
Trading symbol DHR/49
Security exchange name NYSE
XML 10 dhr-20221020_htm.xml IDEA: XBRL DOCUMENT 0000313616 2022-10-20 2022-10-20 0000313616 us-gaap:CommonStockMember 2022-10-20 2022-10-20 0000313616 us-gaap:SeriesBPreferredStockMember 2022-10-20 2022-10-20 0000313616 dhr:A1.7SeniorNotesDue2024Member 2022-10-20 2022-10-20 0000313616 dhr:A0.2SeniorNotesDue2026Member 2022-10-20 2022-10-20 0000313616 dhr:A2.1SeniorNotesDue2026Member 2022-10-20 2022-10-20 0000313616 dhr:A1.2SeniorNotesDue2027Member 2022-10-20 2022-10-20 0000313616 dhr:A0.45SeniorNotesDue2028Member 2022-10-20 2022-10-20 0000313616 dhr:A2.5SeniorNotesDue2030Member 2022-10-20 2022-10-20 0000313616 dhr:A0.75SeniorNotesDue2031Member 2022-10-20 2022-10-20 0000313616 dhr:A1.35SeniorNotesDue2039Member 2022-10-20 2022-10-20 0000313616 dhr:A1.8SeniorNotesDue2049Member 2022-10-20 2022-10-20 false 0000313616 8-K 2022-10-20 DANAHER CORPORATION DE 001-08089 59-1995548 2200 Pennsylvania Avenue, N.W., 20037-1701 Suite 800W Washington, DC 202 828-0850 false false false false Common stock, $0.01 par value DHR NYSE 5.00% Mandatory Convertible Preferred Stock, Series B, without par value DHR.PRB NYSE 1.700% Senior Notes due 2024 DHR 24 NYSE 0.200% Senior Notes due 2026 DHR/26 NYSE 2.100% Senior Notes due 2026 DHR 26 NYSE 1.200% Senior Notes due 2027 DHR/27 NYSE 0.450% Senior Notes due 2028 DHR/28 NYSE 2.500% Senior Notes due 2030 DHR 30 NYSE 0.750% Senior Notes due 2031 DHR/31 NYSE 1.350% Senior Notes due 2039 DHR/39 NYSE 1.800% Senior Notes due 2049 DHR/49 NYSE false EXCEL 11 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

/4U4ZJJ+G0 $ #P" / M " 3X3 !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4 " !7 MCU-5)!Z;HJT #X 0 &@ @ &K% >&PO7W)E;',O=V]R M:V)O;VLN>&UL+G)E;'-02P$"% ,4 " !7CU-599!YDAD! #/ P $P M @ &0%0 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08 "0 ) + #X" #:%@ ! end XML 12 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 13 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 14 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.2.2 html 12 23 1 false 11 0 false 0 false false R1.htm 0001001 - Document - Document And Entity Information Document And Entity Information Sheet http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation Document And Entity Information Document And Entity Information Cover 1 false false All Reports Book All Reports dhr-20221020.htm dhr-20221020.xsd dhr-20221020_def.xml dhr-20221020_lab.xml dhr-20221020_pre.xml dhr-20221020xex991.htm dhr-20221020_g1.jpg http://xbrl.sec.gov/dei/2022 true false JSON 16 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "dhr-20221020.htm": { "axisCustom": 0, "axisStandard": 1, "contextCount": 12, "dts": { "definitionLink": { "local": [ "dhr-20221020_def.xml" ] }, "inline": { "local": [ "dhr-20221020.htm" ] }, "labelLink": { "local": [ "dhr-20221020_lab.xml" ] }, "presentationLink": { "local": [ "dhr-20221020_pre.xml" ] }, "schema": { "local": [ "dhr-20221020.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 39, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 23, "memberCustom": 9, "memberStandard": 2, "nsprefix": "dhr", "nsuri": "http://www.danaher.com/20221020", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dhr-20221020.htm", "contextRef": "iccd927bba4634686bff9ba34f4105ec0_D20221020-20221020", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001001 - Document - Document And Entity Information Document And Entity Information", "role": "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation", "shortName": "Document And Entity Information Document And Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dhr-20221020.htm", "contextRef": "iccd927bba4634686bff9ba34f4105ec0_D20221020-20221020", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 11, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City area code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document period end date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity address, address line one" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity address, address line two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity address, city" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity address, postal zip code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity address, state" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity central index key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity emerging growth company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity file number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity incorporation, state" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityListingsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Entity Listings [Line Items]", "terseLabel": "Entity Listings [Line Items]" } } }, "localname": "EntityListingsLineItems", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_EntityListingsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container for exchange listing information for an entity", "label": "Entity Listings [Table]", "terseLabel": "Entity Listings [Table]" } } }, "localname": "EntityListingsTable", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity registrant name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity tax identification number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local phone number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement issuer tender offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement tender offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security exchange name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dhr_A0.2SeniorNotesDue2026Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "0.2% Senior Notes Due 2026 [Member]", "label": "0.2% Senior Notes Due 2026 [Member]", "terseLabel": "0.200% Senior Notes due 2026" } } }, "localname": "A0.2SeniorNotesDue2026Member", "nsuri": "http://www.danaher.com/20221020", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "dhr_A0.45SeniorNotesDue2028Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "0.45% Senior Notes Due 2028 [Member]", "label": "0.45% Senior Notes Due 2028 [Member]", "terseLabel": "0.450% Senior Notes due 2028" } } }, "localname": "A0.45SeniorNotesDue2028Member", "nsuri": "http://www.danaher.com/20221020", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "dhr_A0.75SeniorNotesDue2031Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "0.75% Senior Notes Due 2031 [Member]", "label": "0.75% Senior Notes Due 2031 [Member]", "terseLabel": "0.750% Senior Notes due 2031" } } }, "localname": "A0.75SeniorNotesDue2031Member", "nsuri": "http://www.danaher.com/20221020", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "dhr_A1.2SeniorNotesDue2027Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "1.2% Senior Notes Due 2027 [Member]", "label": "1.2% Senior Notes Due 2027 [Member]", "terseLabel": "1.200% Senior Notes due 2027" } } }, "localname": "A1.2SeniorNotesDue2027Member", "nsuri": "http://www.danaher.com/20221020", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "dhr_A1.35SeniorNotesDue2039Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "1.35% Senior Notes Due 2039 [Member]", "label": "1.35% Senior Notes Due 2039 [Member]", "terseLabel": "1.350% Senior Notes due 2039" } } }, "localname": "A1.35SeniorNotesDue2039Member", "nsuri": "http://www.danaher.com/20221020", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "dhr_A1.7SeniorNotesDue2024Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "1.7% Senior Notes Due 202 [Member]", "label": "1.7% Senior Notes Due 2024 [Member]", "terseLabel": "1.700% Senior Notes due 2024" } } }, "localname": "A1.7SeniorNotesDue2024Member", "nsuri": "http://www.danaher.com/20221020", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "dhr_A1.8SeniorNotesDue2049Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "1.8% Senior Notes Due 2049 [Member]", "label": "1.8% Senior Notes Due 2049 [Member]", "terseLabel": "1.800% Senior Notes due 2049" } } }, "localname": "A1.8SeniorNotesDue2049Member", "nsuri": "http://www.danaher.com/20221020", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "dhr_A2.1SeniorNotesDue2026Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2.1% Senior Notes Due 2026 [Member]", "label": "2.1% Senior Notes Due 2026 [Member]", "terseLabel": "2.100% Senior Notes due 2026" } } }, "localname": "A2.1SeniorNotesDue2026Member", "nsuri": "http://www.danaher.com/20221020", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "dhr_A2.5SeniorNotesDue2030Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2.5% Senior Notes Due 2030 [Member]", "label": "2.5% Senior Notes Due 2030 [Member]", "terseLabel": "2.500% Senior Notes due 2030" } } }, "localname": "A2.5SeniorNotesDue2030Member", "nsuri": "http://www.danaher.com/20221020", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Stock [Member]", "terseLabel": "Common stock, $0.01 par value" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "us-gaap_SeriesBPreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Series B Preferred Stock [Member]", "terseLabel": "5.00%\u00a0Mandatory Convertible Preferred\u00a0Stock, Series B, without par value" } } }, "localname": "SeriesBPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]", "terseLabel": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.danaher.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "stringItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 17 0000313616-22-000227-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000313616-22-000227-xbrl.zip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